Technology to keep more healthcare in the home will be in demand as providers work harder to keep long hospital stays to a minimum. But remote technology also has made life easier for medtech companies that have been holding status meetings with the FDA via teleconference. Tracy Eberly, CEO of Fang Consulting (Roseville, Minn.), said change doesn’t come quickly at the FDA, but adoption of virtual meetings would be welcomed by industry.
“There are a lot of people who are saying, `Finally, and can we not go back to making us fly to Washington to present for an hour?’” he said on the DeviceTalks Weekly podcast.